could have on health-care companies and what investors should do? Matt, thanks so much for joining me, today. Matthew Coffina : Thanks for having me, Jeremy. Glaser: So, let's talk a little bit about what the Supreme Court has decided
By Morningstar : By Matthew Coffina We have generally been favorable on the managed-care organizations over the past four years, as the stocks were put on sale
By Morningstar : By Matthew Coffina Walgreen ( WAG ) needs a new strategic direction. Its services are becoming increasingly commodified, as its convenience advantage
By Morningstar : By Matthew Coffina , CFA AmerisourceBergen ( ABC ) offers terrific consistency. The company felt few ill effects from health reform, the recession
third quarter), Todd Combs is making a decent-sized bet on a firm whose outlook, in the opinion of our analyst, Matthew Coffina , seems to fundamentally shift every few weeks. In his view, CVS Caremark could provide a model for the future of
Medco Health Solutions MHS, a deal that has about a 50% chance of going through, according to Morningstar analyst Matthew Coffina , CFA. But even with this handicap, Coffina thinks the shares are undervalued. Here is what he has to say about
welcome Matt Coffina, who is an equity analyst in charge of managed care here at Morningstar. Matt, thanks for coming Matthew Coffina : Thanks for having me, Erik. Kobayashi-Solomon : Okay, so back in November of last year, you co-authored
merge in a $29 billion deal. I'm here today with Matthew Coffina --he is an equity analyst at Morningstar--to ..... care industry? Matt, thanks joining me today. Matthew Coffina : Thanks for having me, Jeremy. Glaser : So, can
UnitedHealth UNH and WellPoint WLP - - that are trading below our consider - buy prices . Morningstar analyst Matthew Coffina believes that investors continue to approach the managed care sector with caution , concerned about the impact that
in the sector , not all of which will be affected in the same way . Earlier this week , Morningstar stock analysts Matthew Coffina ( in this note ) and Alex Morozov ( in this video report ) reviewed the new law's provisions and discussed what